Editorial (Thematic Issue: Targeting Epithelial-to-Mesenchymal Transition for Cancer Therapy)

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|10|1239-1239

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.10, 2015-03, pp. : 1239-1239

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EDITORIAL (Thematic Issue: Emerging Roles of Epithelial-to-Mesenchymal Transition in Tumorigenesis)

By  

Current Cancer Drug Targets, Vol. 13, Iss. 9, 2013-12 ,pp. : 905-905

Bentham Science Publishers

Access to resources Recommend Favorite

Is the Epithelial-to-Mesenchymal Transition Clinically Relevant for the Cancer Patient?

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 11, 2011-11 ,pp. : 1891-1899

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Targeting Telomere Maintenance Mechanisms in Cancer Therapy)

By  

Current Pharmaceutical Design, Vol. 20, Iss. 41, 2014-12 ,pp. : 6359-6360

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Pathways Contributing to Epithelial-Mesenchymal Transition (EMT) in Epithelial Ovarian Cancer

By  

Current Drug Targets, Vol. 13, Iss. 13, 2012-12 ,pp. : 1649-1653

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Epithelial-Mesenchymal Transition Phenotype for Gastro-Intestinal Cancer

By  

Current Pharmaceutical Design, Vol. 21, Iss. 21, 2015-06 ,pp. : 2942-2955

Bentham Science Publishers

Access to resources Recommend Favorite